nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

15.06.2022 | Letter to the Editor

Letter to the editor regarding “Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival”

verfasst von: Maria José Veloza Vega, Manuela Gallo, Gonzalo Ucros, Patricia Bernal

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 11/2022

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Jannin A, Lamartina L, Moutarde C, Djennaoui M, Lion G, Chevalier B, Vantyghem MC, Deschamps F, Hadoux J, Baudin E, Schlumberger M, Leboulleux S, Do Cao C. Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival. Eur J Nucl Med Mol Imaging. 2022;49(7):2401–13. https://doi.org/10.1007/s00259-022-05697-w.

World Health Organization International Agency for Research on Cancer (IARC). GLOBOCAN 2020: Colombia fact sheets. [homepage on the internet]; 2020 [cited 2022 March 28]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/170-colombia-fact-sheets.pdf.

Chung J-K, Cheon GJ. Radioiodine therapy in differentiated thyroid cancer: the first targeted therapy in oncology. Endocrinol Metab. 2014;29:233. https://doi.org/10.3803/enm.2014.29.3.233.CrossRef

Titel: Letter to the editor regarding “Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival”
verfasst von: Maria José Veloza Vega
Manuela Gallo
Gonzalo Ucros
Patricia Bernal
Publikationsdatum: 15.06.2022
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 11/2022
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-022-05869-8

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2022

In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy

Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0

Artificial intelligence-based PET denoising could allow a two-fold reduction in [18F]FDG PET acquisition time in digital PET/CT

Imaging joint infections using D-methyl-11C-methionine PET/MRI: initial experience in humans

Classification of 18F-Flutemetamol scans in cognitively normal older adults using machine learning trained with neuropathology as ground truth

[18F]PSMA-1007 PET/CT in the detection of neoplastic lumbosacral plexopathy as an emerging and underestimated spread of prostate cancer